Meridian Bioscience, Inc. Reports First Quarter 2012 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2012 Guidance

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc. (NASDAQ: VIVO):

GENERAL HIGHLIGHTS

Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today:

•reported first quarter net sales of $40.3 million, an increase of 8% from the same period of the prior fiscal year; •reported first quarter operating income of $9.8 million, an increase of 8% over the same period of the prior fiscal year